已收录 273513 条政策
 政策提纲
  • 暂无提纲
Therapeutic and Adverse Effects of Glucantime Used for Treatment of Cutaneous Leishmaniasis.
[摘要] Introduction:CutaneousleishmaniasisisendemicinIran.Fasaregion(SouthernwestofIran)isoneofthehotspots.Themostpopulardrugfortreatmentofcutaneousleishmaniasisisglucantime.Aim:TostudythetherapeuticandadverseeffectsofGlucantimeincutaneousleishmaniasispatientsandalsocomparingtheintramuscularandintralesionaladministrationroutes.MaterialsandMethods:Allnewcutaneousleishmaniasiscases(880)thatwerediagnosedwithintwoyearsofstudywereruledin.Intralesionalinjectionwasusedforsolitarynonfacialwounds,formaximumof10doses,injectedeveryotherday.Formultiplelesionsorfaciallesions,intramuscularinjectionwasperformed,indailymannerformaximumofthree10dayperiods,apartby10daysofdrugfreeintervals.InjectionsweredoneaccordingtoWHOguidelines.Results:Therecoveryratewas84.03%and75.98%inintramuscularandintralesionalinjectiongroups,respectively.Themostcommonsideeffectwasskinhypersensitivityandurticaria,whichwasmoreseeninthosewithintralesionalinjection(10.92%incomparisonwith2.59%inIMgroup).Nocardiacorrenalcomplicationwasobserved.Conclusion:CompleterecoveryishigherinintramuscularinjectioncomparedtointralesionalinjectionofGlucantimeforcutaneousleishmaniasis.Sideeffectsarealsolessseenintheintramuscularinjection.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 基础医学
[关键词] Cutaneous leishmaniasis;Glucantime. [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文